bps sigopac bristol october 2016 - liz price : commissioning cancer as a long-term condition

39
Liz Price, Senior Strategy Lead (Living with and beyond cancer) Transforming Cancer Services Team for London Making progress on Demonstrating Quality and outcomes in psycho-oncology Bristol, 18 October 2016 1 Commissioning cancer as a long term condition

Upload: alex-king

Post on 13-Apr-2017

202 views

Category:

Healthcare


0 download

TRANSCRIPT

Page 1: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

1

Liz Price, Senior Strategy Lead (Living with and beyond cancer)Transforming Cancer Services Team for London

Making progress on Demonstrating Quality and outcomes in psycho-oncology

Bristol, 18 October 2016

Commissioning cancer as a long term condition

Page 2: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

2

Page 3: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

TCST’s LWBC team objectives

We develop guidance and provide strategic support to commissioners on the local planning and delivery of:

• The cancer recovery package and stratified follow up pathways

• The management of consequences of treatment (physical, psychological, social)

• Cancer as a long term condition and integrated care

We work with our partners in London to achieve these objectives: including London’s CCGs and STP cancer boards, UCLH

Collaborative (London Cancer), Royal Marsden Partners, South East London ACN, Macmillan and other charities. We always involve

service users and clinicians in developing our guidance.

[email protected] 3

Page 4: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

4

London 32 CCGs, 5 STP footprints, 8.6m people plus ~3m commuters daily

Page 5: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

5

A message from Dr Pawan RandevTCST GP Advisor, Primary Care Cancer Lead, CCG governing body member

Page 6: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

01

Transforming London’s health and care together6

Policy and evidence

Page 7: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

7

Recap on cancer prevalence

• Cancer remains the leading cause of mortality (NHSE).

• 1 in 2 people will get cancer sometime in their life (CRUK).

• In 2010, over 2m people living with and beyond cancer in the UK; rising to 4m by 2030 (Macmillan).

• In 2013, 223,500 people in London LWBC. Expect around 387,000 people by 2030.

• 70% of people who have cancer, have at least one other long term condition (Macmillan).

• Around 1600 GP practices in London. Average of 149 people with cancer per practice and around 8 new diagnoses per GP per year.

Page 8: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

8

National policy drivers

Page 9: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

9

Regional policy and guidanceImportant in improving access to psychological support for people affected by cancer

Page 10: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

10

Evidence for cancer as a long term conditionThere are specific issues for patients with cancer that would benefit from a holistic, long term conditions approach:

• 94% of people with cancer experience physical health problems in their first year after treatment

• 70% of people who live with and beyond cancer have at least one other long term condition

• 64% of people living with cancer have practical or personal support needs, and 78% have emotional support needs; the majority (75%) of which say that these needs are caused by their cancer or cancer treatment.

• 58% of people feel their emotional needs are not looked after as much as their physical needs.

• At diagnosis, half of all patients experience anxiety and depression sufficient to impair their quality of life. One quarter will have ongoing symptoms for the next six months. Psychological morbidity impacts upon not just quality of life, but survival.

• Of those who receive social care support, more people receive this 18 months after their cancer diagnosis. Social care use for those with cancer is less than for those with other chronic diseases.

• Late effects of radiotherapy and chemotherapy can lead to a raised risk of new primary cancers, heart disease, diabetes, osteoporosis, cognitive dysfunction/dementia, hypothyroidism.

• There is increasing evidence of the importance of diet and physical activity to: reduce likelihood of new primary cancers, reduce rates of cancer recurring, manage the physical and psychological effects of treatment.

• Evidence from the United States shows that exercise following a cancer diagnosis can prevent recurrence of cancer by 40% - this is more cost effective than chemotherapy and much greater reduction in patients developing consequences of cancer treatment.

Page 11: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

02

Transforming London’s health and care together11

Model of care for LWBC

Page 12: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

Layers of patient perspectives

Prevention, screening, diagnosis, treatment, LWB, end of life care12

One patient with all their

holistic needs

identified

All prostate cancer patients

All patients with

psycho-oncology

needs, any tumour type

All cancersAll long

term conditions

All NHS care

All health and social

care

Page 13: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

13

1. Recovery package

Routine use of the ‘recovery package’

A combination of different interventions, which when delivered together, greatly improves the outcomes and coordination of care for people living with and beyond cancer.  Interventions support people to self manage to the best of their ability.

Primary care should receive copies of the Holistic Needs Assessments with an up to date care plan (subject to patient consent) and the Treatment Summary so that they can conduct holistic cancer care reviews and support patients to self manage.

Page 14: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

14

2. Stratified follow up pathways

Implement stratified pathways of care

The clinical team and the person living with cancer make a joint decision about the best form of aftercare based on:

• their knowledge of the disease (what type of cancer and what is likely to happen next)

• the treatment (what the effects or consequences may be both in the short term and long term)

• the person (whether they have other illnesses or conditions, and how much support that they feel they need).

Page 15: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

15

3. Consequences of Treatment

Consequences of treatment (short term and late effects)

Lymphoedema, Pelvic radiation disease, Sexual dysfunction (men and women), Fertility, Psychological support, Hormone symptoms, Cancer related fatigue, pain management etc.

Pre/rehabilitation from point of diagnosis

Physical activity, Vocational rehabilitation.

Page 16: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

16

4. Long term conditions management

“The House of Care takes a whole system approach to LTC management. It makes the person central to care. It is about aligning levers, drivers, evidence and assets to enhance the quality of life for people with long term conditions no matter what or how many conditions they have.”

Page 17: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

03

Transforming London’s health and care together17

How does commissioning work?

Page 18: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

18

Commissioning cycleThere is a commissioning process (not time bound), and a planning round (set out in NHSE planning guidance).

1. Analysis and prioritisation

- Population segmentation

- Initial assessment- Prioritisation

2. Pathway strategy & planning

- Market profiling- Intervention strategy- Stakeholder testing- Implementation and procurement planning

3.Implementation- Procurement (rules apply)

- Analysis of incumbent provider performance

- Signalling of intentions, common baseline & data

- Negotiate contract and agree development plans

4. Manage contractual relationship- Ongoing performance evaluation and management

Time Tasks

Q2 Commence planning, identifying needs, prioritisation, develop headline commissioning intentions for engagement.

Q3 Developing detailed commissioning intentions and understanding financial situation.30 September – date when commissioners and providers must give 6 months notice in writing re any intentions for the following year (to commission/decommission). This is specified in NHS Standard Contract.

Q4 Contract negotiations – agreeing Heads of Terms including total financial envelope. By 31st March, full contracts to be signed off which includes Heads of Terms, detailed Finance & Activity, KPIs, Information Requirements, CQUINs etc.

Q1 Negotiations of specific schedules in the contract can overspill to a “long stop” date (often this is 30 June).

Page 19: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

19

Population health needs assessmentHow do we know what services we need?

A Joint Strategic Needs Assessment (JSNA) looks at the current and future health and care needs of local populations to inform and guide the planning and commissioning (buying) of health, well-being and social care services within a local authority area. The JSNA:

Is concerned with wider social factors that have an impact on people’s health and wellbeing, such as housing, poverty and employment.

Looks at the health of the population, with a focus on behaviours which affect health such as smoking, diet and exercise.

Provides a common view of health and care needs for the local community

Identifies health inequalities

Provides evidence of effectiveness for different health and care interventions

Documents current service provision

Identifies gaps in health and care services, documenting unmet needs

Page 20: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

20

System architectureHow are stakeholders involved in transformation, service redesign, performance management?

Page 21: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

21

NHS Standard contractWhat is the point of contracts? How are they used?

3 Parts – particulars, service conditions and general conditions

Particulars (the schedules):

1. Service commencement and contract term

2. Services - specifications, specialist service derogations, activity, safeguarding etc

3. Payment – local prices, variations etc

4. Quality requirements – operational standards, national and local quality standards, CQUINs, local incentive schemes etc

5. Governance – subcontractors, commissioner roles & responsibilities

6. Contract management & reporting – information requirements, data quality improvement plans, incident reporting, service development plans, surveys.

Page 22: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

04

Transforming London’s health and care together22

What data do we track in London?

Page 23: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

20 Year Prevalence in England (Crude Rate) 1991-2013London prevalence is well below the England average

Sources: Public Health England (NCIN), Population estimates (ONS)23

Page 24: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

24

Prevalence of common cancersPrevalence: Crude rate of registered cancer patients alive at 31/12/2013 (breast, colorectal, prostate).

Source: Public Health England (NCIN)

STP Breast Colorectal Prostate

North Central London 9928 3190 5322

North East London 10621 2702 7427

North West London 14814 2640 6772

South East London 12320 2662 6449

South West London 11868 2532 6952

London 59,551 13,726 32,922

Page 25: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

25

The Cancer Patient Experience Survey (2015)The CPES tells us that there is a marked difference between patient satisfaction of their stay in hospital compared to that of the support provided by primary and community care. Patient satisfaction with support following discharge is even worse.

SPG CCG Overall how would you rate

your care(Q59)

Do you think the GPs and nurses at your GPs did everything

they could to support during your cancer

treatment? (Q53

Were you given enough care and support from

health or social services (Q51)

Best in England Adjusted scores 8.9 65% 64%

England average All England CCGs 8.7 63% 45%

London average 8.5 57% 38%

North Central London

Barnet 8.4 55% 28%

Enfield 8.4 54% 27%

Haringey 8.4 56% 29%

Camden 8.7 59% 50%

Islington 8.7 57% 36%

East London City & Hackney 8.1 54% 48%

Tower Hamlets 8.2 62% 41%

Newham 8.2 46% 21%

Waltham Forest 8.3 49% 31%

Redbridge 8.4 54% 40%

Barking & Dagenham 8.4 61% 30%

Havering 8.6 63% 46%

Source: National Cancer Patient Experience Survey (2015)

Page 26: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

26

SPG CCG Overall how would you rate your care

(Q59)

Do you think the GPs and nurses at your GPs did everything

they could to support during your cancer treatment? (Q53)

Were you given enough care and support from

health or social services (Q51)

South East London Lambeth 8.6 62% 43%

Southwark 8.3 53% 39%

Lewisham 8.4 49% 27%

Greenwich 8.6 57% 39%

Bexley 8.8 57% 44%

Bromley 8.6 51% 46%

South West London

Wandsworth 8.6 65% 35%

Richmond 8.5 56% 45%

Kingston 8.6 56% 27%

Merton 8.6 59% 36%

Sutton 8.9 57% 41%

Croydon 8.6 57% 35%

North West London

Central London 8.6 61% 46%

West London 8.8 72% 53%

H’smith & Fulham 8.4 47% 38%

Brent 8.4 58% 39%

Ealing 8.5 58% 39%

Hounslow 8.5 51% 32%

Harrow 8.4 62% 33%

Hillingdon 8.7 58% 41%

Source: National Cancer Patient Experience Survey (2014)

Page 27: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

GP – QOF CAN002: Patient Review within 6 months of diagnosisThere are no national quality standards on what a good CCR should cover

Sources: HSCIC QOF Data (http://www.hscic.gov.uk/catalogue/PUB18887)

NOTE: This metric uses a 15 month reporting cycle – therefore it represents patients diagnosed from Jan 14 – Mar 15

CCG Name

Percentage of patients receiving

intervention

NHS WEST LONDON CCG 72.52 NHS CENTRAL LONDON (WESTMINSTER) CCG 74.69 NHS REDBRIDGE CCG 77.57 NHS HAMMERSMITH AND FULHAM CCG 77.87 NHS EALING CCG 78.19 NHS ISLINGTON CCG 78.69 NHS WEST ESSEX CCG 78.97 NHS WALTHAM FOREST CCG 79.53 NHS LEWISHAM CCG 79.60 NHS CITY AND HACKNEY CCG 79.88 NHS SOUTHWARK CCG 80.06 NHS BROMLEY CCG 80.20 NHS BEXLEY CCG 80.87 NHS CAMDEN CCG 81.41 NHS CROYDON CCG 82.14 NHS NEWHAM CCG 82.33 NHS MERTON CCG 82.34 NHS HILLINGDON CCG 82.64 NHS HOUNSLOW CCG 82.64 NHS TOWER HAMLETS CCG 82.76 NHS HARINGEY CCG 82.82 NHS LAMBETH CCG 83.01 NHS BRENT CCG 83.10 NHS SUTTON CCG 83.25 NHS HARROW CCG 83.78 NHS KINGSTON CCG 84.05 NHS BARNET CCG 84.36 NHS BARKING AND DAGENHAM CCG 84.62 NHS HAVERING CCG 85.21 NHS GREENWICH CCG 85.50 NHS WANDSWORTH CCG 85.76 NHS ENFIELD CCG 86.05 NHS RICHMOND CCG 89.10

NH

S W

EST

LON

DO

N C

CGN

HS

CEN

TRAL

LO

ND

ON

(WES

TMIN

STER

) CCG

NH

S RE

DBR

IDG

E CC

GN

HS

HAM

MER

SMIT

H A

ND

FU

LHAM

CCG

NH

S EA

LIN

G C

CGN

HS

ISLI

NG

TON

CCG

NH

S W

EST

ESSE

X CC

GN

HS

WAL

THAM

FO

REST

CCG

NH

S LE

WIS

HAM

CCG

NH

S CI

TY A

ND

HAC

KNEY

CCG

NH

S SO

UTH

WAR

K CC

GN

HS

BRO

MLE

Y CC

GN

HS

BEXL

EY C

CGN

HS

CAM

DEN

CCG

NH

S CR

OYD

ON

CCG

NH

S N

EWH

AM C

CGN

HS

MER

TON

CCG

NH

S H

ILLI

NG

DO

N C

CGN

HS

HO

UN

SLO

W C

CGN

HS

TOW

ER H

AMLE

TS C

CGN

HS

HAR

ING

EY C

CGN

HS

LAM

BETH

CCG

NH

S BR

ENT

CCG

NH

S SU

TTO

N C

CGN

HS

HAR

ROW

CCG

NH

S KI

NG

STO

N C

CGN

HS

BARN

ET C

CGN

HS

BARK

ING

AN

D D

AGEN

HAM

CCG

NH

S H

AVER

ING

CCG

NH

S G

REEN

WIC

H C

CGN

HS

WAN

DSW

ORT

H C

CGN

HS

ENFI

ELD

CCG

NH

S RI

CHM

ON

D C

CG

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

CAN002 - Patient Review within 6 months of diagnosis (2014-15)

27

Page 28: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

GP – QOF CAN001: Cancer Register Compliance

Sources: HSCIC QOF Data (http://www.hscic.gov.uk/catalogue/PUB18887)

CCG NameAchievement

rate(per cent)

NHS CENTRAL LONDON (WESTMINSTER) CCG 97.06 NHS BARKING AND DAGENHAM CCG 100.00 NHS BARNET CCG 100.00 NHS CAMDEN CCG 100.00 NHS CITY AND HACKNEY CCG 100.00 NHS ENFIELD CCG 100.00 NHS HARINGEY CCG 100.00 NHS HAVERING CCG 100.00 NHS ISLINGTON CCG 100.00 NHS NEWHAM CCG 100.00 NHS REDBRIDGE CCG 100.00 NHS TOWER HAMLETS CCG 100.00 NHS WALTHAM FOREST CCG 100.00 NHS BRENT CCG 100.00 NHS EALING CCG 100.00 NHS HOUNSLOW CCG 100.00 NHS HAMMERSMITH AND FULHAM CCG 100.00 NHS HARROW CCG 100.00 NHS HILLINGDON CCG 100.00 NHS WEST LONDON CCG 100.00 NHS BEXLEY CCG 100.00 NHS BROMLEY CCG 100.00 NHS CROYDON CCG 100.00 NHS GREENWICH CCG 100.00 NHS KINGSTON CCG 100.00 NHS LAMBETH CCG 100.00 NHS LEWISHAM CCG 100.00 NHS RICHMOND CCG 100.00 NHS SOUTHWARK CCG 100.00 NHS MERTON CCG 100.00 NHS SUTTON CCG 100.00 NHS WANDSWORTH CCG 100.00 NHS WEST ESSEX CCG 100.00

NH

S CE

NTR

AL L

ON

DO

N (W

ESTM

INST

ER) C

CGN

HS

BARK

ING

AN

D D

AGEN

HAM

CCG

NH

S BA

RNET

CCG

NH

S CA

MD

EN C

CGN

HS

CITY

AN

D H

ACKN

EY C

CGN

HS

ENFI

ELD

CCG

NH

S H

ARIN

GEY

CCG

NH

S H

AVER

ING

CCG

NH

S IS

LIN

GTO

N C

CGN

HS

NEW

HAM

CCG

NH

S RE

DBR

IDG

E CC

GN

HS

TOW

ER H

AMLE

TS C

CGN

HS

WAL

THAM

FO

REST

CCG

NH

S BR

ENT

CCG

NH

S EA

LIN

G C

CGN

HS

HO

UN

SLO

W C

CGN

HS

HAM

MER

SMIT

H A

ND

FU

LHAM

CCG

NH

S H

ARRO

W C

CGN

HS

HIL

LIN

GD

ON

CCG

NH

S W

EST

LON

DO

N C

CGN

HS

BEXL

EY C

CGN

HS

BRO

MLE

Y CC

GN

HS

CRO

YDO

N C

CGN

HS

GRE

ENW

ICH

CCG

NH

S KI

NG

STO

N C

CGN

HS

LAM

BETH

CCG

NH

S LE

WIS

HAM

CCG

NH

S RI

CHM

ON

D C

CGN

HS

SOU

THW

ARK

CCG

NH

S M

ERTO

N C

CGN

HS

SUTT

ON

CCG

NH

S W

AND

SWO

RTH

CCG

NH

S W

EST

ESSE

X CC

G

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

CAN001 - Cancer Register Compliance (2014-15)

28

Page 29: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

29

CI 12: Recovery Package – Holistic Needs Assessment (70% of new patients in 15/16)

% of patients receiving element of the recovery package is an estimate derived by comparing the number of patients reported by the trust against the number of first treated patients reported.

Che

lsea

and

Wes

tmin

ster

NH

S F

ound

atio

n T

rust

Cro

ydon

Hea

lth S

ervi

ces

NH

S T

rust

Eps

om a

nd S

t Hel

ier

NH

S T

rust

Guy

s an

d S

t Tho

mas

' NH

S F

ound

atio

n T

rust

Impe

rial C

olle

ge H

ealth

care

NH

S T

rust

Kin

gs C

olle

ge H

ospi

tal N

HS

Fou

ndat

ion

Tru

st

Kin

gsto

n H

ospi

tal N

HS

Tru

st

Lew

isha

m a

nd G

reen

wic

h H

ealth

care

NH

S T

rust

Lond

on N

orth

Wes

t Hea

lthca

re N

HS

Tru

st

Roy

al B

rom

pton

& H

aref

ield

NH

S T

rust

St G

eorg

es H

ealth

care

NH

S T

rust

The

Hilli

ingd

on N

HS

Fou

ndat

ion

Tru

st

The

Roy

al M

arsd

en N

HS

Fou

ndat

ion

Tru

st

Wes

t Mid

dles

ex U

nive

rsity

NH

S T

rust

Bar

ts H

ealth

NH

S T

rust

Bar

king

Hav

erin

g R

edbr

idge

Uni

vers

ity T

rust

Hom

erto

n U

nive

rsity

NH

S T

rust

The

Nor

th M

iddl

esex

Uni

vers

ity H

ospi

tal N

HS

Tru

st

The

Prin

cess

Ale

xand

ra H

ospi

tal N

HS

Tru

st

The

Roy

al F

ree

Hos

pita

l NH

S T

rust

Uni

vers

ity C

olle

ge o

f Lon

don

Hos

pita

l NH

S F

ound

atio

n...

The

Whi

tting

ton

Hos

pita

l NH

S T

rust

-10.0%

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

100.0%

110.0%

120.0%

130.0%

140.0%% of patients with HNA within 31 days of diagnosis 2015/16

Threshold

Page 30: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

30

London eHNA + concerns checklistIn the last 12 months, 38% of care plans identify worry, fear or anxiety as a concern for the patient at any point on the cancer pathway. About 15 Trusts in currently London are using eHNA.

Page 31: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

31

CI 12: Recovery Package – Treatment Summary (70% of new patients in 15/16)

% of patients receiving element of the recovery package is an estimate derived by comparing the number of patients reported by the trust against the number of first treated patients reported.

Che

lsea

and

Wes

tmin

ster

NH

S F

ound

atio

n T

rust

Cro

ydon

Hea

lth S

ervi

ces

NH

S T

rust

Eps

om a

nd S

t Hel

ier

NH

S T

rust

Guy

s an

d S

t Tho

mas

' NH

S F

ound

atio

n T

rust

Impe

rial C

olle

ge H

ealth

care

NH

S T

rust

Kin

gs C

olle

ge H

ospi

tal N

HS

Fou

ndat

ion

Tru

st

Kin

gsto

n H

ospi

tal N

HS

Tru

st

Lew

isha

m a

nd G

reen

wic

h H

ealth

care

NH

S T

rust

Lond

on N

orth

Wes

t Hea

lthca

re N

HS

Tru

st

Roy

al B

rom

pton

& H

aref

ield

NH

S T

rust

St G

eorg

es H

ealth

care

NH

S T

rust

The

Hilli

ingd

on N

HS

Fou

ndat

ion

Tru

st

The

Roy

al M

arsd

en N

HS

Fou

ndat

ion

Tru

st

Wes

t Mid

dles

ex U

nive

rsity

NH

S T

rust

Bar

ts H

ealth

NH

S T

rust

Bar

king

Hav

erin

g R

edbr

idge

Uni

vers

ity T

rust

Hom

erto

n U

nive

rsity

NH

S T

rust

The

Nor

th M

iddl

esex

Uni

vers

ity H

ospi

tal N

HS

Tru

st

The

Prin

cess

Ale

xand

ra H

ospi

tal N

HS

Tru

st

The

Roy

al F

ree

Hos

pita

l NH

S T

rust

Uni

vers

ity C

olle

ge o

f Lon

don

Hos

pita

l NH

S F

ound

at...

The

Whi

tting

ton

Hos

pita

l NH

S T

rust

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

100.0%

% of patients with treatment summary within 6 weeks of end of treatment 2015/16

Threshold

Page 32: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

32

CI 12: Recovery Package – Health & wellbeing events/clinics (70% of new patients in 15/16)

% of patients receiving element of the recovery package is an estimate derived by comparing the number of patients reported by the trust against the number of first treated patients reported.

Che

lsea

and

Wes

tmin

ster

NH

S F

ound

atio

n ...

Cro

ydon

Hea

lth S

ervi

ces

NH

S T

rust

Eps

om a

nd S

t Hel

ier

NH

S T

rust

Guy

s an

d S

t Tho

mas

' NH

S F

ound

atio

n T

rust

Impe

rial C

olle

ge H

ealth

care

NH

S T

rust

Kin

gs C

olle

ge H

ospi

tal N

HS

Fou

ndat

ion

Tru

st

Kin

gsto

n H

ospi

tal N

HS

Tru

st

Lew

isha

m a

nd G

reen

wic

h H

ealth

care

NH

S ..

.

Lond

on N

orth

Wes

t Hea

lthca

re N

HS

Tru

st

Roy

al B

rom

pton

& H

aref

ield

NH

S T

rust

St G

eorg

es H

ealth

care

NH

S T

rust

The

Hilli

ingd

on N

HS

Fou

ndat

ion

Tru

st

The

Roy

al M

arsd

en N

HS

Fou

ndat

ion

Tru

st

Wes

t Mid

dles

ex U

nive

rsity

NH

S T

rust

Bar

ts H

ealth

NH

S T

rust

Bar

king

Hav

erin

g R

edbr

idge

Uni

vers

ity T

rust

Hom

erto

n U

nive

rsity

NH

S T

rust

The

Nor

th M

iddl

esex

Uni

vers

ity H

ospi

tal N

H...

The

Prin

cess

Ale

xand

ra H

ospi

tal N

HS

Tru

st

The

Roy

al F

ree

Hos

pita

l NH

S T

rust

Uni

vers

ity C

olle

ge o

f Lon

don

Hos

pita

l NH

S ..

.

The

Whi

tting

ton

Hos

pita

l NH

S T

rust

-10.0%

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

100.0%

110.0%

120.0% % of patients attending Health and Well being event 2015/16

Threshold

Page 33: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

33

CI 12: Recovery Package – Stratified Pathways (Breast – 70%, Colorectal - 40% Prostate – 40%)

% of patients receiving element of the recovery package is an estimate derived by comparing the number of patients reported by the trust against the number of first treated patients reported.

Page 34: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

05

Transforming London’s health and care together34

So what?

Page 35: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

35

Data is kingCommissioners (and planners) use data to justify new or change in expenditure to benefit the whole population for their whole lifetime

Sustainability and transformation plans (STPs) are increasingly taking on responsibility for asking (and answering) these kinds of questions:

• What are the outcomes in our area?

• Where are our gaps/inadequacies in service delivery?

• What differences in outcomes exist amongst our population?

• How well are our services integrated? Acute & community/primary care, physical & mental health, health & social care?

• What benefits will our population get from this investment?

• What happens if we don’t invest at all/ enough?

• How do we prioritise?

• How efficient can we be/ are we?

• How long can we sustain this kind of investment?

• How do we invest? What service models/contracting models should we use?

• How do we compare to other similar areas?

Page 36: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

36

Discussion – how do we compare?

1. How confident are you in answering each of these lines of enquiry, using robust evidence? On a scale 1-10 (10 very confident)

2. Which LOEs are most difficult to answer and why? Your top 3

3. What do we need to do to improve our answers? Plenary discussion

• What are the outcomes in our area?

• Where are our gaps/inadequacies in service delivery?

• What differences in outcomes exist amongst our population?

• How well are our services integrated? Acute & community/primary care, physical & mental health, health & social care?

• What benefits will our population get from this investment?

• What happens if we don’t invest at all/ enough?

• How do we prioritise?

• How efficient can we be/ are we?

• How long can we sustain this kind of investment?

• How do we invest? What service models/contracting models should we use?

In small groups/with your neighbours…

Page 37: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

37

Key messages• For commissioners, data is king. And benchmarked data is even better!

• The numbers of people surviving cancer are increasing, and people are also living longer following a cancer diagnosis.

• Cancer is a long term condition. 70% of people with cancer have at least one other long term condition.

• Significant need arising from consequences of treatment can be prevented or better managed. Requires good commissioning and provision

• 15 months after diagnosis, people with cancer are more likely to use urgent and emergency care services compared to others in the same age and gender groups.

• 58% of people feel their emotional needs are not looked after as much as their physical needs.

• The Recovery Package and stratified follow up needs to be integrated into cancer pathways and extend across secondary and primary care to provide co-ordinated and holistic care to support for people in the long term.

Page 38: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

38

Recovery package LWBC Commissioning Guidance: Recovery Package (2015) Treatment Summaries: a briefing for cancer GPs (2016) 

Cancer Care Reviews & integrated care

Cancer as a long term condition report (2015) Primary Care Cancer Checklist (2016) 

Primary care education LWBC Training Needs Analysis surveys for the primary care workforce (2016)o GPs https://www.surveymonkey.co.uk/r/LWBC_GP o GP Trainees https://www.surveymonkey.co.uk/r/LWBC_trainee_GPso Primary Care nurses https://www.surveymonkey.co.uk/r/LWBC_Primary_care_nurseso Community pharmacists and dentists (in development)o Community allied health professionals (in development)

Prospectus (in development)

Prostate cancer (Primary care led follow up)

Croydon Primary Care led Prostate Cancer follow Up project evaluation (2016) ICF’s Economic Analysis (2016) Desktop review of the Prostate Cancer UK projects in London (2016) CCG/STP sample business case (2016) 

Stratified follow up pathways (hospital led)

Financial modelling tools (in development)o London Cancer colorectal cancer pathwayo London Cancer prostate cancer pathwayo London Cancer breast cancer pathway

 Cancer Rehabilitation Psychological support for people affected by cancer: commissioning guidance (2015)

Pathway and service specification for psychological support for people affected by cancer (in development)

Lymphoedema commissioning guidance (2016) Cancer Rehabilitation commissioning guidance (in development) 

Accessing TCST resources

Page 39: BPS SIGOPAC Bristol October 2016 - Liz Price : Commissioning Cancer As a Long-Term Condition

39

Contact [email protected]

https://www.myhealth.london.nhs.uk/healthy-london/programmes/cancer